glp-1 news today 2025 october 9 Drugs Are Rewriting the Rules of Food Mapping the effectiveness and risks

However, it is important to recognise when professional support may be helpful

Policymakers and clinicians should continue to closely monitor trade-offs between pharmacologic and surgical management of obesity to ensure optimal access to effective obesity treatment, the researchers concluded.

10.1038/s41591-025-03608-8 217

doi:10.5301/jva.5000511

AS GLP-1s ORIGINALLY INTENDED TO TREAT TYPE 2 DIABETES (T2D) AND OFTEN DELIVERED WITH INJECTION PENS DEVELOPED FOR INSULIN ARE INCREASINGLY USED TO TREAT OBESITY, PERHAPS IT IS WORTH RETHINKING THE BASIS OF THESE DESIGNS TO ACCOMMODATE A USER GROUP THAT MAY HAVE DIFFERENT REQUIREMENTS. People with diabetes depend on these devices for survival, and the devices have been optimised accordingly for their ease of use, safety and reliability

Hyperinsulinemia, which refers to abnormally high amounts of insulin in the bloodstream, can lead to an elevation in the synthesis of androgens